Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Reyon Pharmaceutical to prepay KRW 110,448,600 of debt before maturity on put option exercise

Reyon Pharmaceutical to prepay KRW 110,448,600 of debt before maturity on put option exercise

BitgetBitget2026/09/28 07:51
  • Reyon Pharmaceutical set an early buyback of KRW 100,000,000 of its 3rd private convertible bond before maturity.
  • Repurchase price KRW 110,448,600, reflecting principal plus interest; payment scheduled for Oct. 26, 2026.
  • Transaction triggered by bondholders’ put option; bonds to be retired following the buyback.
  • Outstanding principal balance to fall to KRW 84.9 billion from KRW 85 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reyon Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260928000281), on September 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46

After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.

Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.

智通财经•2026/09/29 02:46

Debt and inflation become the biggest constraints! Deutsche Bank warns: The global market "policy safety net" is failing and future volatility may intensify

Deutsche Bank Research stated in its latest report that the era of large-scale policy interventions used to cushion global economic shocks over the past decades is coming to an end. The continuous rise in sovereign debt, high interest rates, and persistent inflation are all weakening the traditional “safety net” relied upon by governments and central banks.

智通财经•2026/09/29 02:46